Clinical Trial Update: Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating toripalimab in combination with gemcitabine and 5-fluorouracil for advanced cholangiocarcinoma is underway but with unknown …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Gemcitabine (Gemcitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Jiangmen Central Hospital | Conditions: Advanced Cholangiocarcinoma | Phase 2 | Status: UNKNOWN